[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100532447":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":20,"locations":26,"responsibleParty":60,"collaborators":19,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":66,"sex":72,"minAge":73,"maxAge":19,"enrollmentInfo":74,"targetDuration":19,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":19,"overallStatus":29,"whyStopped":19,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"University of Tartu","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Patient with suspicion of acute mesenteric ischaemia","Bolld samples is the only intervention. All patients with suspicion of AMI will be included and blood samples collected",[12],"Diagnostic Test: Sequential blood samples",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","Sequential blood samples","Sequential blood samples for diagnostic tests is the only intervention in thei study",[9],null,[21],{"name":22,"role":23,"phone":24,"phoneExt":19,"email":25},"Annika Reintam Blaser, PhD","CONTACT","+3725142281","annika.reintam.blaser@ut.ee",[27,44],{"facility":28,"status":29,"city":30,"state":19,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Tartu University Hospital","RECRUITING","Tartu","50406","Estonia","EE",{"type":35,"coordinates":36},"Point",[37,38],26.72509,58.38062,{"lat":38,"lon":37},[41],{"name":42,"role":23,"phone":43,"phoneExt":19,"email":19},"Joel Starkopf, PhD","+3727318405",{"facility":45,"status":29,"city":46,"state":19,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":54,"contacts":55},"Lucerne Cantonal Hospital","Lucerne","6000","Switzerland","CH",{"type":35,"coordinates":51},[52,53],8.30635,47.05048,{"lat":53,"lon":52},[56],{"name":57,"role":23,"phone":58,"phoneExt":19,"email":59},"Juan Celi de la Torre, MD","+41412051886","juan.celidelatorre@luks.ch",{"type":61,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Annika Reintam Blaser","Associate Professor","100532447","biomarkers-in-prediction-of-ami-100532447",false,"NCT06212921","Biomarkers in Prediction of AMI","Biomarkers In Prediction of Acute Mesenteric Ischaemia: a Prospective Multicentre Study (BIPAMI Study)","BIPAMI","Inclusion Criteria:\n\n* Age 18 years or older\n* Initial decision in favour of further diagnostics of mesenteric ischaemia\n\nExclusion Criteria:\n\n* Age \\\u003C18 years\n* Consent declined by patient or next of kin (delayed consent)\n* Chronic mesenteric ischaemia without an acute event\n* Immediate decision for withdrawal of further diagnostics and active treatment\n* Referral from another hospital with already established diagnosis of AMI\n* AMI diagnosed at surgery without previously having been considered","ALL","18 Years",{"count":75,"type":76},250,"ESTIMATED","INTERVENTIONAL",[79],"NA","Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.",[82],"Acute Mesenteric Ischemia","2024-11-27",{"date":85,"type":86},"2024-12-03","ACTUAL",{"date":88,"type":86},"2024-10-14",{"date":90,"type":76},"2025-12",{"name":5,"class":6},2]